Back to search results

Adapting Support for Parents of Young Adults with Cancer

This study is testing a new version of a support program called SMART-3RP for parents whose adolescent or young adult child (ages 15-39) has cancer. The program, a Psychosocial Intervention, aims to help parents reduce their stress and improve their well-being. Researchers will first adapt the program based on feedback from parents, then test how practical and helpful it is. They want to see if parents find it easy to join and complete, and if it helps reduce their distress. The study plans to enroll 48 participants and is currently unclear about its recruitment status. You may be able to join if you are a parent over 18, are the primary caregiver for a child aged 15-39 with cancer, and are experiencing some distress.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 48 participants to test the adapted support program.
What's involved
Participation involves completing the adapted SMART-3RP program. The time from enrollment to treatment completion is approximately 3 months.
Compensation
Not stated in the trial record.
Follow-up
The study measures outcomes at post-treatment completion, which is approximately 3 months after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07139769

Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

Recruiting
NAAges 18+InterventionalSupportive care
Zeba Ahmad, Ph.D.
~48 participants
Updated 2026-08-25 on ClinicalTrials.gov
What's tested:Psychosocial Intervention for Parental Caregivers of AYA with Cancer

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll
Measured over Post-treatment completion (enrollment to treatment completion is approximately 3 months)
+2 more outcomes measured

Conditions

Caregiving for Cancer

Explore related trials

Caregiver stressors

Where it's being run

1 sites across 1 states
Massachusetts1

Who to contact

Zeba N Ahmad, Ph.D.
[email protected]
16177241586
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer
Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer at the Mass General Brigham Cancer
Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer
English-speaking
Aged over 18 years

Exclusion

Active symptoms of psychosis or suicidal ideation that would preclude safe participation

What this trial measures

  • Intervention Feasibility: Percent of Identified Prospective Participants Who EnrollPost-treatment completion (enrollment to treatment completion is approximately 3 months)

    Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.

  • Intervention Feasibility: Proportion of Participants Completing the ProgramPost-treatment completion (enrollment to treatment completion is approximately 3 months)

    Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.

  • Intervention AcceptabilityPost-treatment completion (enrollment to treatment completion is approximately 3 months)

    Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).